20 – Trends in the vaccine market and health systems

in page functions

This session brought together a wealth of experience from countries, manufacturers, partners and donors to explore the complex interplays between vaccines markets, health and immunisation systems

GAVI.10.Riccardo Gangale_Rwanda_0256_mod copyF

Copyright GAVI/2010/Riccardo Gangale

Vaccine markets and health systems are constantly evolving and having to respond to changing supply and demand dynamics.

This special session brought together a wealth of experience from countries, manufacturers, partners and donors to explore the complex interplays between vaccines markets, health and immunisation systems.

The challenges associated with the distribution and delivery of health and immunisation services and commodities were emphasised by JSI, with Carolyn Hart stressing “it is time to move away from vertical supply chains to ensure all our public health products get to the people who need them.”

Chris Elias from the Bill and Melinda Gates Foundation also focused on supply chain issues: “Half of GAVI eligible countries have had a vaccine stock out in the last four years – we need to think of this as a value chain, not just a supply chain. We lose value every time we miss an opportunity to reach and vaccinate children.

There was encouragement for us to focus on positive innovations, which don’t always need huge investments. We can foster innovation within our current means and within our current systems to improve immunisation and health systems.

Two prominent vaccine developers, Serum Institute and Novartis also shared their views. They highlighted the central role of political will for vaccines, as well as the positive trends in new vaccines now being launched almost simultaneously in both developed and developing countries.

The need to strengthen health and immunisation systems to cope with an expanding portfolio of vaccines was emphasised when two countries shared their reflections on this engaging topic. Benin highlighted that “integration of our systems are important and we must not forget that we cannot increase immunisation coverage without a well performing health system.

Moldova concluded with some examples of the challenges faced by graduating countries, which were echoed by Flavia Bustreo from WHO, who also emphasised the need to consider sustainability.

168 million

GAVI-supported vaccine campaigns have resulted in 100 million individuals being immunised against meningitis A and 68 million against yellow fever since 2000.

Meningitis A Conjugate Vaccine Immunizaton Campaign. Joint WHO/UNICEF 2011 Progress Report: January to December 2012. March 2013, p.3 | 2011 data. Yellow Fever Initiative. Joint WHO and UNICEF 2011 Progress Report Nov 2012, p.13, 15. 2012 data: Based on data from Epidemiology of Yellow Fever in the African Region: 2012 report. WHO Regional Office for Africa. April 2013, p.6.

More facts...

close icon

modal window here